Interactive Transcript
0:01
Hello everyone, Sydney Levy here continuing our
0:03
discussion of the formal TNM staging of oral cavity
0:08
malignancy according to the most recent American Joint
0:11
Cancer Committee guidelines published in early 2018.
0:17
We have our example case of an oral tongue
0:21
malignancy, which we have already staged
0:24
according to T stage in our last vignette.
0:27
In this vignette, I would like
0:28
to focus on the lymph nodes.
0:31
There has been a major change since the 7th
0:34
edition guidelines in that now every oral cavity
0:39
or oropharyngeal or indeed upper aerodigestive
0:42
tract malignancy needs to be documented
0:46
as either human papillomavirus negative or
0:49
positive before a formal stage can be given.
0:53
And that's a very important change
0:55
because there has been a change in the
0:57
demographic of which people get
1:01
oral cavity and oropharyngeal malignancy.
1:04
We are now seeing a younger demographic of
1:06
people who have human papillomavirus positivity.
1:11
And those people tend to have a better
1:13
prognosis, and it's resulted in a
1:15
requirement to change the N staging.
1:18
So after that introduction, I'd like to go on to
1:22
our study in which we have three lymph nodes that we
1:26
can see that are clearly morphologically abnormal.
1:29
I have the pre-contrast T1 and the post-contrast T1
1:33
with fat suppression in the top half, and I have the
1:37
T2 with fat suppression in the coronal projection,
1:41
and the sagittal post-contrast T1 with fat suppression.
1:45
The first thing you need to do is to
1:48
identify whether lymph nodes are present
1:51
on one or both sides of the neck.
1:55
In this case, it is bilateral and
1:58
this already upgrades the N stage.
2:01
I'm going to begin with the N stage for an
2:04
HPV, or human papillomavirus, negative tumor.
2:08
There are three lymph nodes here,
2:10
two on the left, one on the right.
2:12
They are situated in left levels 2a extending into
2:17
3 and on the right situated within right level 2a.
2:22
You identify that to refresh people's memory
2:25
by the inferior border of the hyoid bone.
2:28
That is the boundary between level
2:30
2 and level 3 in levels of the neck.
2:34
The next thing you need to do is to measure the
2:37
maximal dimension of the largest lymph node.
2:40
That is often seen in the sagittal projection.
2:43
So that's something to keep in mind.
2:45
It's often best to look in the sagittal projection
2:48
because that is usually where you will get your
2:50
maximal dimension for levels two, three, and four.
2:55
In this case, we have a 27 millimeter
2:59
lymph node and therefore it falls
3:02
under the threshold of six centimeters,
3:05
which is important for staging.
3:08
Lastly, there is no radiologic evidence
3:11
to suggest extranodal extension,
3:13
such as an infiltrative nodal margin.
3:15
So we can stage this tumor, we are
3:19
calling HPV negative, as an N2C tumor.
3:24
And the reason for that is bilateral
3:27
lymphadenopathy, and none of the lymph
3:30
nodes are more than six centimeters.
3:33
And there is no radiologic
3:34
evidence of extranodal extension.
3:37
Lastly, we must comment as to whether
3:39
there is any evidence of distant disease,
3:41
and this is where modalities such as
3:43
PET CT and CT assume primary importance.
3:48
There is no evidence of distant
3:49
disease in this particular example.
3:51
So in summary, for an HPV negative tumor,
3:55
this is an N2C tumor, it's bilateral,
3:59
and the lymph nodes measure less than 6 cm.
4:02
The last thing to remember is if it's an HPV positive
4:06
tumor, which are more common in the oropharynx but
4:10
do occur in the oral cavity, it becomes an N2 tumor.
4:15
And the way that we work that out,
4:17
it's actually a lot simpler.
4:19
If you have bilateral disease and it's less
4:22
than 6 centimeters, it's N2, as opposed
4:25
to ipsilateral disease, which is N1.
4:29
Thank you.
© 2025 Medality. All Rights Reserved.